study for pregnancy of unknown location monitoring
Part of Women’s health & pregnancy clinical trials.
This study is looking at women with a pregnancy of unknown location (PUL) who need hCG monitoring, and healthy volunteers for comparison. It aims to learn more about PUL and may help improve care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be diagnosed with a pregnancy of unknown location (PUL) and need ongoing blood tests to check your hCG levels.
- You cannot have kidney disease or diabetes (type 1 or type 2).
- You cannot have a history of any cancer or gestational trophoblastic disease.
- If you are a control participant (without PUL), you must not be pregnant and must not have used hormonal birth control in the last 3 months.
- If you have PUL, you must not have a very high initial hCG level (over 100,000 mIU/mL) or signs of a ruptured ectopic pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a quick blood test that helps doctors figure out if a pregnancy of unknown location is likely to be a normal pregnancy or an ectopic pregnancy (where the pregnancy grows outside the uterus). It aims to give you a faster and more accurate risk assessment so you get the right care sooner.
This study uses a scope placed in the uterus to find and treat a pregnancy that can't be located on ultrasound. It may help women with slow-rising pregnancy hormone levels find out where the pregnancy is and get treatment at the same time.
This study tests a new blood test to track how the body responds to treatment during pregnancy, especially for those at risk of high blood pressure conditions. It may help doctors monitor and improve care.
This trial tests a new ultrasound system to see if it can take clear pictures of a single baby during pregnancy. It may help improve care for expecting mothers.
This study is for people who have a pregnancy-related tumor called gestational trophoblastic disease. It looks at this condition in patients who were diagnosed by blood test (hCG) changes or tissue testing, to better understand and manage the disease.
This study tests whether using a small ultrasound device at home can help monitor high-risk pregnancies in people with gestational diabetes. You would perform quick scans and share them with your doctor remotely.
Hear when a new Pregnancy of Unknown Location (PUL) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.